Inotrem is a French clinical-stage biotechnology company developing therapies for dysregulated innate immune responses and inflammation. Its lead candidate, nangibotide (LR12)…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Inotrem →Already a subscriber? Sign in
Xcout Intel tracks Inotrem continuously — this profile deepens as new filings, funding, people and hiring data arrive.